PT1463563E - Miméticos de dismutase do superóxido para o tratamento de distúrbios e doenças oculares - Google Patents

Miméticos de dismutase do superóxido para o tratamento de distúrbios e doenças oculares Download PDF

Info

Publication number
PT1463563E
PT1463563E PT02786915T PT02786915T PT1463563E PT 1463563 E PT1463563 E PT 1463563E PT 02786915 T PT02786915 T PT 02786915T PT 02786915 T PT02786915 T PT 02786915T PT 1463563 E PT1463563 E PT 1463563E
Authority
PT
Portugal
Prior art keywords
treatment
diseases
superoxide dismutase
ocular disorders
dismutase mimics
Prior art date
Application number
PT02786915T
Other languages
English (en)
Inventor
Peter G Klimko
Mark R Hellberg
Robert J Collier Jr
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of PT1463563E publication Critical patent/PT1463563E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
PT02786915T 2001-12-14 2002-12-06 Miméticos de dismutase do superóxido para o tratamento de distúrbios e doenças oculares PT1463563E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34038901P 2001-12-14 2001-12-14

Publications (1)

Publication Number Publication Date
PT1463563E true PT1463563E (pt) 2009-03-19

Family

ID=23333158

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02786915T PT1463563E (pt) 2001-12-14 2002-12-06 Miméticos de dismutase do superóxido para o tratamento de distúrbios e doenças oculares

Country Status (19)

Country Link
US (2) US7759333B2 (pt)
EP (1) EP1463563B1 (pt)
JP (1) JP2005513063A (pt)
KR (1) KR100951606B1 (pt)
CN (2) CN1620325A (pt)
AT (1) ATE422944T1 (pt)
BR (1) BR0214957A (pt)
CA (1) CA2470721C (pt)
CY (1) CY1108983T1 (pt)
DE (1) DE60231246D1 (pt)
DK (1) DK1463563T3 (pt)
ES (1) ES2319399T3 (pt)
HK (1) HK1069785A1 (pt)
MX (1) MXPA04005601A (pt)
PL (1) PL210225B1 (pt)
PT (1) PT1463563E (pt)
SI (1) SI1463563T1 (pt)
WO (1) WO2003051458A1 (pt)
ZA (1) ZA200404435B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1463563T3 (da) * 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme
EP1691815A4 (en) * 2003-12-11 2010-03-31 Alcon Inc SUPEROXIDE DISMUTASE MIMETICS FOR THE TREATMENT OF OPTIC AND RETINA DAMAGE
US7803931B2 (en) 2004-02-12 2010-09-28 Archemix Corp. Aptamer therapeutics useful in the treatment of complement-related disorders
US8598150B1 (en) 2008-04-02 2013-12-03 Jonathan R. Brestoff Composition and method for affecting obesity and related conditions
US8987245B2 (en) 2008-04-02 2015-03-24 Jonathan R. Brestoff Parker Composition and method for affecting obesity and related conditions
CA2747161C (en) 2008-12-19 2017-07-18 Abbott Laboratories (hetero)aryl substituted (benzo[d]thiazol-2-ylcarbamoyl) 1,2,3,4-tetrahydroquinolins and related compounds and uses thereof for treating cancer and excess platelets
EP2433640B1 (en) 2010-09-24 2020-01-15 OmniVision GmbH Composition comprising SOD, lutein and zeaxanthin
KR101214364B1 (ko) * 2011-02-15 2012-12-21 한림대학교 산학협력단 수퍼옥사이드 디스뮤테이즈 융합 단백질을 함유하는 안과 질환 예방 또는 치료용 약제학적 조성물
JP6267638B2 (ja) * 2011-09-26 2018-01-24 ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーＧａｌｅｒａ Ｌａｂｓ， Ｌｌｃ 疾患の治療方法
WO2023120828A1 (ko) * 2021-12-23 2023-06-29 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 건성 황반변성의 예방 또는 치료용 용도
WO2023224136A1 (ko) * 2022-05-16 2023-11-23 주식회사 제노포커스 수퍼옥시드 디스뮤타제 및 이의 당뇨망막병증 또는 포도막염의 예방 또는 치료용 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5209926A (en) * 1990-06-12 1993-05-11 Insite Vision Incorporated Aminosteroids for ophthalmic use
US6127356A (en) * 1993-10-15 2000-10-03 Duke University Oxidant scavengers
US5994339A (en) * 1993-10-15 1999-11-30 University Of Alabama At Birmingham Research Foundation Oxidant scavengers
SE9402816D0 (sv) 1994-08-24 1994-08-24 Pharmacia Ab Method and meams for drug administration
US6214817B1 (en) * 1997-06-20 2001-04-10 Monsanto Company Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
US6180620B1 (en) 1997-06-20 2001-01-30 G.D. Searle & Co. Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
EP1045851B1 (en) 1997-11-03 2003-04-23 Duke University Substituted porphyrins
WO2000007584A2 (en) 1998-08-04 2000-02-17 Wisconsin Alumni Research Foundation Method of reducing retinal ganglion cell degeneration
GB9817845D0 (en) * 1998-08-17 1998-10-14 Glaxo Group Ltd Chemical compounds
WO2000023568A2 (en) 1998-10-06 2000-04-27 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells
EP1185312B1 (en) 1999-05-27 2005-03-23 Monsanto Company Biomaterials modified with superoxide dismutase mimics
DK1463563T3 (da) 2001-12-14 2009-04-20 Alcon Inc Superoxiddismutas-mimetika til behandling af öjenlidelser og -sygdomme

Also Published As

Publication number Publication date
CY1108983T1 (el) 2014-07-02
HK1069785A1 (en) 2005-06-03
US7759333B2 (en) 2010-07-20
WO2003051458A1 (en) 2003-06-26
MXPA04005601A (es) 2004-12-06
AU2002351267A1 (en) 2003-06-30
SI1463563T1 (sl) 2009-06-30
ZA200404435B (en) 2006-05-31
KR20040063943A (ko) 2004-07-14
US20100204194A1 (en) 2010-08-12
CN1620325A (zh) 2005-05-25
EP1463563A1 (en) 2004-10-06
PL369607A1 (en) 2005-05-02
US8003635B2 (en) 2011-08-23
ES2319399T3 (es) 2009-05-07
CA2470721A1 (en) 2003-06-26
ATE422944T1 (de) 2009-03-15
DK1463563T3 (da) 2009-04-20
CA2470721C (en) 2011-07-12
DE60231246D1 (de) 2009-04-02
JP2005513063A (ja) 2005-05-12
BR0214957A (pt) 2004-12-14
CN101092432A (zh) 2007-12-26
AU2002351267B2 (en) 2007-04-05
EP1463563B1 (en) 2009-02-18
US20050032768A1 (en) 2005-02-10
PL210225B1 (pl) 2011-12-30
KR100951606B1 (ko) 2010-04-09

Similar Documents

Publication Publication Date Title
HK1069785A1 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
WO2004052227A3 (en) Superoxide dismutase mimics for the treatment of ocular disorders and diseases
WO2002085248A3 (en) Prostanoids augment ocular drug penetration
WO2006069078A3 (en) Treatment of anal incontinence
MXPA04011612A (es) Uso oftalmologico de roflumilasto para el tratamiento de enfermedades del ojo.
AU780906C (en) Use of biochemical substances for a composition for the prevention and treatment of health conditions caused by constriction of smooth muscle cells in organs of the human body
AP1750A (en) Methods for treating ocular neovascular diseases
PL396553A1 (pl) Zastosowanie czynnika do wytwarzania leku do leczenia jaskry
AU2002234806A1 (en) Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders
MXPA03010655A (es) Gel oft??lmico de pirenzepina.
WO2001068053A3 (en) Methods and compositions for treating and preventing posterior segment ophthalmic disorders
MXPA04000124A (es) Composicion farmaceutica para la terapia de cistitis intersticial.
MXPA03009273A (es) AGENTE PARA EL TRATAMIENTO OFTaLMICO TOPICO DE LAS ENFERMEDADES INFLAMATORIAS OCULARES.
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
EP1567166A4 (en) SUPEROXIDE DISMUTASE MIMIC FOR THE TREATMENT OF EYE DISORDER AND DISEASES
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AU2001267864A1 (en) Remedial agent for optic nerve disease and the like
HK1045258A1 (en) Glutathione reductase for therapy and prophylaxis of aids
WO2005058911A3 (en) Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma
BRPI0417549A (pt) miméticos de superóxido dismutase para o tratamento de lesão de nervo óptico e retinal
MXPA05012696A (es) Formulaciones de agentes antiinflamatorios no esteroides para tratar angiogenesis ocular patologica.
DE60215864D1 (de) Behandlung von okularen neovaskularen erkrankungen
UA29333A (uk) Очна мазь
UA40487A (uk) Спосіб хірургічного лікування хворих з сторонніми тілами, локалізованими в "пограничній зоні" ока, та відшаруванням сітківки